Pharmacotheraphy in fibromyalgia syndrome

Basit Öğe Kaydı
dc.contributor.authorÖzgöçmen, S.
dc.contributor.authorArdiço?lu, Ö.
dc.date.accessioned2026-08-12T16:11:08Z
dc.date.issued2000
dc.departmentFırat Üniversitesi
dc.description.abstractFibromyalgia syndrome is a chronic pain syndrome characterised by widespread pain and tenderness of musculokeletal structures. Alternatives in pharmacological treatment of this syndrome are so limited. In this paper drugs used in the treatment of fibromyalgia syndrome are reviewed.
dc.identifier.endpage88
dc.identifier.issn1016-5134
dc.identifier.issue12
dc.identifier.scopus2-s2.0-0034438929
dc.identifier.scopusqualityN/A
dc.identifier.startpage84
dc.identifier.urihttps://hdl.handle.net/11508/42319
dc.identifier.volume12
dc.indekslendigikaynakScopus
dc.language.isotr
dc.relation.ispartofSENDROM
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectalprazolam; amitriptyline; benzodiazepine derivative; clomipramine; cyclobenzaprine; dosulepin; maprotiline; serotonin; serotonin uptake inhibitor; tricyclic antidepressant agent; chronic pain; clinical trial; depression; drug indication; fibromyalgia; human; musculoskeletal system; review
dc.titlePharmacotheraphy in fibromyalgia syndrome
dc.title.alternativeFibromiyalji sendromunda farmakoterapi
dc.typeReview Article

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu